当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Emily S. Sagalow
COVID- 19 is a new coronavirus that was linked in December 2019. After public lockdown restrictions were legislated in March 2020, COVID-19 affected the practice of numerous specialties, including otolaryngology. Otolaryngology was supposed to be a high- threat specialty for COVID- 19 transmission due to its primary focus on the nasopharynx and respiratory tract and to the substantial aerosol product during operative procedures. Multitudinous studies have indicated the localization of large viral loads in the nasal epithelial cells, with the nasal depression and nasopharynx having the loftiest attention of contagion in the upper respiratory tract. These factors, in combination with reports of shy particular defensive outfit and delayed reversal time for individual testing, placed otolaryngology providers at high threat during surgical procedures in the early stages of the epidemic [1].